Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）
Conditions
- Chronic Kidney Disease Stage 4
Interventions
- DRUG: Henagliflozin 5 mg Group
- DRUG: Henagliflozin 10 mg Group
- DRUG: Conventional therapy group
Sponsor
First Affiliated Hospital of Wannan Medical College
Collaborators